AxoGen
Latest round
- Series D
Last raised
- Jan 2010
Total raised
- $22M
Investors
- 4
About AxoGen
AxoGen develops surgical solutions for peripheral nerve repair, focusing on biological products that aid in nerve regeneration.1 mn in AxoGen.AxoGen specializes in surgical solutions for peripheral nerve repair, primarily offering products designed to restore feeling and functionality to damaged peripheral nerves. Their flagship product, the Avance® Nerve Graft, serves as a biological solution for nerve repair, allowing for the regeneration of nerves after injury. The company’s offerings are employed by a range of medical professionals, including hand surgeons, reconstructive plastic surgeons, and oral and maxillofacial surgeons, in various surgical procedures aimed at addressing nerve injuries. The primary end users of Axogen's products are patients suffering from nerve damage due to traumatic events, such as accidents or surgeries, who seek to regain mobility and sensory function.28 mn. The company generates revenue through a direct sales model, supplying its nerve repair products to healthcare providers and surgical specialists.1 mn to enhance its product development and expand its market presence. The company is focused on introducing new products aimed at improving peripheral nerve repair solutions. As part of its growth strategy, AxoGen is targeting expansion into additional international markets by 2026, aiming to increase the accessibility of its nerve repair technologies.
Who invested in AxoGen
4 investors across 3 rounds
See all investors in AxoGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AxoGen
Who invested in AxoGen?
AxoGen has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AxoGen raised?
AxoGen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did AxoGen last raise money?
AxoGen's most recent round on record is a Series D, in Jan 2010.
What does AxoGen do?
AxoGen develops surgical solutions for peripheral nerve repair, focusing on biological products that aid in nerve regeneration.
Where is AxoGen headquartered?
AxoGen is headquartered in Alachua, US.
Which VCs invest in companies like AxoGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at AxoGen's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like AxoGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.